NEW YORK (GenomeWeb) – Memorial Sloan Kettering Cancer Center has partnered with Quest Diagnostics to use molecular testing of patients' tumors to provide better treatment options and understand the genomic underpinnings of the disease.

In the first phase of the collaboration, Memorial Sloan Kettering will provide contextual information about the mutations identified in a next-generation sequencing-based test developed by Quest and will contribute to the clinical annotation report provided to physicians.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.